-
公开(公告)号:EP1957496B1
公开(公告)日:2012-10-24
申请号:EP06844779.6
申请日:2006-12-04
发明人: CREW, Andrew Philip , DONG, Han-Qing , MULVIHILL, Mark Joseph , WERNER, Douglas S. , KADALBAJOO, Mridula , LAUFER, Radoslaw
IPC分类号: C07D487/04 , A61P35/00 , A61P31/00 , A61P29/00 , A61K31/4985
CPC分类号: C07D487/04
-
公开(公告)号:EP1957496A2
公开(公告)日:2008-08-20
申请号:EP06844779.6
申请日:2006-12-04
发明人: CREW, Andrew Philip , DONG, Han-Qing , MULVIHILL, Mark Joseph , WERNER, Douglas S. , KADALBAJOO, Mridula , LAUFER, Radoslaw
IPC分类号: C07D487/04 , A61P35/00 , A61P31/00 , A61P29/00 , A61K31/4985
CPC分类号: C07D487/04
摘要: Compounds of the Formula (I) and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit protein kinase enzymes and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
-